explore -WSS

explore

author：leisure time 2025-09-29 21:12:59 - browse：31

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Victims of gun violence feel impacts long after bullet wound

WSS

PhRMA sues HHS over Medicare drug price negotiation

Inside the fall of star MIT scientist David Sabatini

Abortion clinic in Cancun will cater to Americans

More doctors should go into startup world

Bacterial infection may be ‘key event’ in endometriosis, study says

Connecting traumatic brain injury and domestic violence

Wikipedia

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Sports medicine is finally prioritizing gender equality

Option Care buys Amedisys in $3.6 billion home care deal

Sports medicine is finally prioritizing gender equality

Extreme heat events are a public health emergency

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

These geoengineering technologies could help combat the climate crisis, scientists say

FDA approval of Sarepta Duchenne genetic therapy gives me hope

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

focus

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Brain 'hot spot' may explain why African Americans feel greater pain

Senate panel clears PBM, hopsital reforms

More doctors should go into startup world

Grail is spending more than ever lobbying Congress

STAT Executive Editor Rick Berke on STAT's 8th birthday

entertainment

entertainment

knowledge

Wikipedia